Market positioning Pharmaceutical and biotech focus with a suite of benchmarking and grant-cost tools suggests strong upsell potential to smaller sponsors and CROs seeking cost transparency, budgeting support, and site submission efficiency.

Cost benchmarking Existing solutions such as CRO CostPro and IISiS indicate opportunity to cross-sell to companies needing cost benchmarking, outsourcing negotiations, and investigator-initiated study insights across global trials.

Data monetization Large database offerings like GrantPlan and Standard of Care position TTC to expand data-as-a-service licenses or tiered access models to pharma, biotech, and contract research organizations.

Revenue scale Current revenue in the low-mid single digits with a small to mid-sized employee base signals room for growth via partnerships, channel sales, and expanding client footprint in global markets.

Tech backbone Microsoft 365 usage implies potential for modernization of collaboration, CRM integration, and secure data sharing; a formal tech stack expansion could enable scalable sales and customer success workflows.